JERUSALEM, Jan 28 (Reuters) - Israel has signed a deal to buy 5 million COVID-19 vaccine doses from Novavax , the country's Health Ministry said on Friday.
The vaccines are due to arrive in Israel in the coming months, pending regulatory approval, the ministry said.
Financial details of the deal, which includes the option for an additional 5 million doses, were not disclosed.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments